Dexamethasone Sodium Phosphate
Dexamethasone Sodium Phosphate Injection, USP Rx only
Approved
Approval ID
8969803e-2e45-1f28-e053-2995a90a05a7
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 15, 2023
Manufacturers
FDA
Medical Purchasing Solutions, LLC
DUNS: 601458529
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Dexamethasone Sodium Phosphate
PRODUCT DETAILS
NDC Product Code71872-7164
Application NumberANDA084282
Marketing CategoryC73584
Route of AdministrationINTRA-ARTICULAR, INTRALESIONAL, INTRAMUSCULAR, INTRAVENOUS, SOFT TISSUE
Effective DateMay 15, 2023
Generic NameDexamethasone Sodium Phosphate
INGREDIENTS (7)
SODIUM SULFITEInactive
Quantity: 1 mg in 1 mL
Code: VTK01UQK3G
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CITRATEInactive
Quantity: 19.4 mg in 1 mL
Code: 1Q73Q2JULR
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
BENZYL ALCOHOLInactive
Quantity: 10.42 mg in 1 mL
Code: LKG8494WBH
Classification: IACT
DEXAMETHASONE SODIUM PHOSPHATEActive
Quantity: 4 mg in 1 mL
Code: AI9376Y64P
Classification: ACTIR
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT